{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:02:38Z","timestamp":1775674958548,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005878","name":"Terveyden Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["330902"],"award-info":[{"award-number":["330902"]}],"id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005878","name":"Terveyden Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["337530"],"award-info":[{"award-number":["337530"]}],"id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6"],"award-info":[{"award-number":["Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State research funding of the Turku University Hospital expert responsibility area","award":["State research funding of the Turku University Hospital expert responsibility area"],"award-info":[{"award-number":["State research funding of the Turku University Hospital expert responsibility area"]}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["National Multiple Sclerosis Society"],"award-info":[{"award-number":["National Multiple Sclerosis Society"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6"],"award-info":[{"award-number":["Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6"]}],"id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-024-01186-3","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T12:59:15Z","timestamp":1733403555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["P2X\u20097-receptor binding in new-onset and secondary progressive MS \u2013 a [11C]SMW139 PET study"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-2549","authenticated-orcid":false,"given":"Jussi","family":"Lehto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Aarnio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jouni","family":"Tuisku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Sucksdorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esa Mikko","family":"Koivum\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjo","family":"Nylund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semi","family":"Helin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Rajander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Danon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayson","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kassiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesa","family":"Oikonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Airas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"1186_CR1","doi-asserted-by":"crossref","unstructured":"Chauveau F, Becker G, Boutin H. Have (R)-[11\u00a0C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies. Eur J Nucl Med Mol Imaging. Springer Science and Business Media Deutschland GmbH; 2021. pp. 201\u201320.","DOI":"10.1007\/s00259-021-05425-w"},{"key":"1186_CR2","doi-asserted-by":"publisher","unstructured":"Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity. Brain [Internet]. 2000;123:2321\u201337. https:\/\/doi.org\/10.1093\/brain\/123.11.2321","DOI":"10.1093\/brain\/123.11.2321"},{"key":"1186_CR3","doi-asserted-by":"crossref","unstructured":"Sucksdorff M, Matilainen M, Tuisku J, Polvinen E, Vuorimaa A, Rokka J et al. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis. Brain [Internet]. 2020;143:3318\u201330. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33006604","DOI":"10.1093\/brain\/awaa275"},{"key":"1186_CR4","doi-asserted-by":"crossref","unstructured":"Rissanen E, Tuisku J, Vahlberg T, Sucksdorff M, Paavilainen T, Parkkola R et al. Microglial activation, white matter tract damage, and disability in MS. Neurol Neuroimmunol Neuroinflamm [Internet]. 2018;5:e443. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29520366","DOI":"10.1212\/NXI.0000000000000443"},{"key":"1186_CR5","doi-asserted-by":"crossref","unstructured":"Misin O, Matilainen M, Nylund M, Honkonen E, Rissanen E, Sucksdorff M et al. Innate Immune Cell\u2013Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis. Neurology - Neuroimmunology Neuroinflammation [Internet]. 2022;9:e1182. http:\/\/nn.neurology.org\/content\/9\/4\/e1182.abstract","DOI":"10.1212\/NXI.0000000000001182"},{"key":"1186_CR6","doi-asserted-by":"crossref","unstructured":"Sucksdorff M, Tuisku J, Matilainen M, Vuorimaa A, Smith S, Keitil\u00e4 J et al. Natalizumab treatment reduces microglial activation in the white matter of the MS brain. Neurol Neuroimmunol Neuroinflamm. 2019;6.","DOI":"10.1212\/NXI.0000000000000574"},{"key":"1186_CR7","doi-asserted-by":"publisher","unstructured":"Lehto J, Sucksdorff M, Nylund M, Raitanen R, Matilainen M, Airas L. PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report. J Neurol [Internet]. 2022 [cited 2023 Jan 24];1:1\u20134. https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s00415-022-11539-4","DOI":"10.1007\/s00415-022-11539-4"},{"key":"1186_CR8","doi-asserted-by":"publisher","unstructured":"Lehto J, Nylund M, Matilainen M, Sucksdorff M, Vuorimaa A, Rajander J et al. Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis. Eur J Neurol [Internet]. 2023;n\/a. https:\/\/doi.org\/10.1111\/ene.15834","DOI":"10.1111\/ene.15834"},{"key":"1186_CR9","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2967\/jnumed.116.183020","volume":"58","author":"M Sucksdorff","year":"2017","unstructured":"Sucksdorff M, Rissanen E, Tuisku J, Nuutinen S, Paavilainen T, Rokka J, et al. Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis. J Nucl Med. 2017;58:1646\u201351.","journal-title":"J Nucl Med"},{"key":"1186_CR10","doi-asserted-by":"publisher","unstructured":"Beaino W, Janssen B, Kooij G, van der Pol SMA, van Het Hof B, van Horssen J et al. Purinergic receptors P2Y12R and P2X7R: Potential targets for PET imaging of microglia phenotypes in multiple sclerosis. J Neuroinflammation [Internet]. 2017 [cited 2023 Feb 7];14:1\u201316. https:\/\/jneuroinflammation.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12974-017-1034-z","DOI":"10.1186\/s12974-017-1034-z"},{"key":"1186_CR11","doi-asserted-by":"crossref","unstructured":"Giovannoni G, Popescu V, Wuerfel J, Hellwig K, Iacobeus E, Jensen MB et al. Smouldering multiple sclerosis: the \u2018real MS.\u2019 Ther. Adv Neurol Disord. 2022;15.","DOI":"10.1177\/17562864211066751"},{"key":"1186_CR12","doi-asserted-by":"crossref","unstructured":"Nylund M, Sucksdorff M, Matilainen M, Polvinen E, Tuisku J, Airas L. Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18\u00a0kDa translocator protein-PET. Brain Commun. 2022;4.","DOI":"10.1093\/braincomms\/fcab301"},{"key":"1186_CR13","doi-asserted-by":"crossref","unstructured":"Monif M, Burnstock G, Williams DA. Microglia: proliferation and activation driven by the P2X7 receptor. Int J Biochem Cell Biol [Internet]. 2010 [cited 2023 Jun 15];42:1753\u20136. https:\/\/pubmed.ncbi.nlm.nih.gov\/20599520\/","DOI":"10.1016\/j.biocel.2010.06.021"},{"key":"1186_CR14","doi-asserted-by":"crossref","unstructured":"Bhattacharya A, Biber K. The microglial ATP-gated ion channel P2X7 as a CNS drug target. Glia [Internet]. 2016 [cited 2023 Jun 15];64:1772\u201387. https:\/\/pubmed.ncbi.nlm.nih.gov\/27219534\/","DOI":"10.1002\/glia.23001"},{"key":"1186_CR15","doi-asserted-by":"crossref","unstructured":"Clark AK, Staniland AA, Marchand F, Kaan TKY, McMahon SB, Malcangio M. P2X7-Dependent Release of Interleukin-1\u03b2 and Nociception in the Spinal Cord following Lipopolysaccharide. The Journal of Neuroscience [Internet]. 2010 [cited 2023 Jun 15];30:573. \/pmc\/articles\/PMC2880485\/","DOI":"10.1523\/JNEUROSCI.3295-09.2010"},{"key":"1186_CR16","doi-asserted-by":"publisher","unstructured":"Fantoni ER, Dal Ben D, Falzoni S, Di Virgilio F, Lovestone S, Gee A. Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7. EJNMMI Res [Internet]. 2017 [cited 2023 Nov 24];7:1\u201312. https:\/\/link.springer.com\/articles\/https:\/\/doi.org\/10.1186\/s13550-017-0275-2","DOI":"10.1186\/s13550-017-0275-2"},{"key":"1186_CR17","doi-asserted-by":"crossref","unstructured":"Territo PR, Meyer JA, Peters JS, Riley AA, McCarthy BP, Gao M et al. Characterization of 11\u00a0C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation. J Nucl Med [Internet]. 2017 [cited 2023 Nov 24];58:458\u201365. https:\/\/pubmed.ncbi.nlm.nih.gov\/27765863\/","DOI":"10.2967\/jnumed.116.181354"},{"key":"1186_CR18","doi-asserted-by":"publisher","unstructured":"Beaino W, Janssen B, Kooijman E, Vos R, Schuit RC, O\u2019Brien-Brown J et al. PET imaging of P2X7R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [11\u00a0C]SMW139. J Neuroinflammation [Internet]. 2020 [cited 2024 Feb 28];17:1\u201318. https:\/\/jneuroinflammation.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12974-020-01962-7","DOI":"10.1186\/s12974-020-01962-7"},{"key":"1186_CR19","doi-asserted-by":"crossref","unstructured":"Burnstock G. P2X ion channel receptors and inflammation. Purinergic Signalling. 2016 12:1 [Internet]. 2016 [cited 2023 Jun 15];12:59\u201367. https:\/\/link.springer.com\/article\/10.1007\/s11302-015-9493-0","DOI":"10.1007\/s11302-015-9493-0"},{"key":"1186_CR20","doi-asserted-by":"crossref","unstructured":"Wilkinson SM, Barron ML, O\u2019Brien-Brown J, Janssen B, Stokes L, Werry EL et al. Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X7 Receptor Antagonist. ACS Chem Neurosci [Internet]. 2017 [cited 2023 Jun 15];8:2374\u201380. https:\/\/pubs.acs.org\/doi\/full\/10.1021\/acschemneuro.7b00272","DOI":"10.1021\/acschemneuro.7b00272"},{"key":"1186_CR21","doi-asserted-by":"crossref","unstructured":"Janssen B, Vugts DJ, Wilkinson SM, Ory D, Chalon S, Hoozemans JJM et al. Identification of the allosteric P2X7 receptor antagonist [11\u00a0C]SMW139 as a PET tracer of microglial activation. Scientific Reports 2018 8:1 [Internet]. 2018 [cited 2023 Jun 15];8:1\u201310. https:\/\/www.nature.com\/articles\/s41598-018-24814-0","DOI":"10.1038\/s41598-018-24814-0"},{"key":"1186_CR22","doi-asserted-by":"publisher","unstructured":"Akaike H. Information Theory and an Extension of Information the Maximum Theory Likelihood and an Principle Extension of the Maximum Likelihood Principle. Biogeochemistry [Internet]. 1998 [cited 2023 Jun 15];1998:199\u2013213. https:\/\/link.springer.com\/chapter\/https:\/\/doi.org\/10.1007\/978-1-4612-1694-0_15","DOI":"10.1007\/978-1-4612-1694-0_15"},{"key":"1186_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00259-019-04550-x","volume":"47","author":"MHJ Hagens","year":"2020","unstructured":"Hagens MHJ, Golla SSV, Janssen B, Vugts DJ, Beaino W, Windhorst AD, et al. The P2X7 receptor tracer [11\u00a0C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study. Eur J Nucl Med Mol Imaging. 2020;47:379\u201389.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1186_CR24","doi-asserted-by":"crossref","unstructured":"Aarnio R, Alzghool OM, Wahlroos S, O\u2019Brien-Brown J, Kassiou M, Solin O et al. Novel plasma protein binding analysis method for a PET tracer and its radiometabolites: A case study with [11\u00a0C]SMW139 to explain the high uptake of radiometabolites in mouse brain. J Pharm Biomed Anal. 2022;219.","DOI":"10.1016\/j.jpba.2022.114860"},{"key":"1186_CR25","doi-asserted-by":"crossref","unstructured":"Brumberg J, Aarnio R, Forsberg A, Marjam\u00e4ki P, Kerstens V, Moein MM et al. Quantification of the purinergic P2X7 receptor with [11\u00a0C]SMW139 improves through correction for brain-penetrating radiometabolites. J Cereb Blood Flow Metab [Internet]. 2023 [cited 2023 Jun 16];43:258\u201368. https:\/\/pubmed.ncbi.nlm.nih.gov\/36163685\/","DOI":"10.1177\/0271678X221126830"},{"key":"1186_CR26","doi-asserted-by":"crossref","unstructured":"Sureau FC, Reader AJ, Comtat C, Leroy C, Ribeiro MJ, Buvat I et al. Impact of image-space resolution modeling for studies with the high-resolution research tomograph. J Nucl Med [Internet]. 2008 [cited 2024 Feb 13];49:1000\u20138. https:\/\/pubmed.ncbi.nlm.nih.gov\/18511844\/","DOI":"10.2967\/jnumed.107.045351"},{"key":"1186_CR27","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1016\/j.neuroimage.2011.11.032","volume":"59","author":"P Schmidt","year":"2012","unstructured":"Schmidt P, Gaser C, Arsic M, Buck D, F\u00f6rschler A, Berthele A, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. NeuroImage. 2012;59:3774\u201383.","journal-title":"NeuroImage"},{"key":"1186_CR28","doi-asserted-by":"crossref","unstructured":"Kanellopoulos JM, Delarasse C. Pleiotropic Roles of P2X7 in the Central Nervous System. Front Cell Neurosci [Internet]. 2019 [cited 2024 Sep 11];13. https:\/\/pubmed.ncbi.nlm.nih.gov\/31551714\/","DOI":"10.3389\/fncel.2019.00401"},{"key":"1186_CR29","doi-asserted-by":"crossref","unstructured":"Nutma E, Stephenson JA, Gorter RP, de Bruin J, Boucherie DM, Donat CK et al. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain [Internet]. 2019;142:3440\u201355. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31578541","DOI":"10.1093\/brain\/awz287"},{"key":"1186_CR30","doi-asserted-by":"crossref","unstructured":"Airas L, Rissanen E, Rinne JO. Imaging neuroinflammation in multiple sclerosis using TSPO-PET. Clin Transl Imaging. Springer-Verlag Italia s.r.l.; 2015. pp. 461\u201373.","DOI":"10.1007\/s40336-015-0147-6"},{"key":"1186_CR31","doi-asserted-by":"crossref","unstructured":"Airas L, Yong VW. Microglia in multiple sclerosis - pathogenesis and imaging. Curr Opin Neurol [Internet]. 2022 [cited 2023 Jan 24];35:299\u2013306. https:\/\/pubmed.ncbi.nlm.nih.gov\/35674072\/","DOI":"10.1097\/WCO.0000000000001045"},{"key":"1186_CR32","doi-asserted-by":"crossref","unstructured":"Bodini B, Tonietto M, Airas L, Stankoff B. Positron emission tomography in multiple sclerosis - straight to the target. Nat Rev Neurol [Internet]. 2021; https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34545219","DOI":"10.1038\/s41582-021-00537-1"},{"key":"1186_CR33","doi-asserted-by":"crossref","unstructured":"Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol [Internet]. 2015 [cited 2024 Jan 5];78:710\u201321. https:\/\/pubmed.ncbi.nlm.nih.gov\/26239536\/","DOI":"10.1002\/ana.24497"},{"key":"1186_CR34","doi-asserted-by":"crossref","unstructured":"Kuhlmann T, Ludwin S, Prat A, Antel J, Br\u00fcck W, Lassmann H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol [Internet]. 2017 [cited 2023 Apr 6];133:13\u201324. https:\/\/pubmed.ncbi.nlm.nih.gov\/27988845\/","DOI":"10.1007\/s00401-016-1653-y"},{"key":"1186_CR35","doi-asserted-by":"publisher","unstructured":"Laaksonen S, Saraste M, Nylund M, Hinz R, Snellman A, Rinne J et al. Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals. Front Neurol [Internet]. 2024 [cited 2024 Feb 28];15:1352116. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fneur.2024.1352116\/full","DOI":"10.3389\/fneur.2024.1352116\/full"},{"key":"1186_CR36","doi-asserted-by":"publisher","unstructured":"Schmidt S, Isaak A, Junker A. Spotlight on P2X7 receptor PET imaging: a bright target or a failing star? Int J Mol Sci. 2023;24(2):1374. https:\/\/doi.org\/10.3390\/ijms24021374.","DOI":"10.3390\/ijms24021374"},{"key":"1186_CR37","doi-asserted-by":"crossref","unstructured":"Guneykaya D, Ivanov A, Hernandez DP, Haage V, Wojtas B, Meyer N et al. Transcriptional and Translational Differences of Microglia from Male and Female Brains. Cell Rep [Internet]. 2018 [cited 2024 Jun 5];24:2773\u20132783.e6. https:\/\/pubmed.ncbi.nlm.nih.gov\/30184509\/","DOI":"10.1016\/j.celrep.2018.08.001"},{"key":"1186_CR38","doi-asserted-by":"crossref","unstructured":"Villa A, Gelosa P, Castiglioni L, Cimino M, Rizzi N, Pepe G et al. Sex-Specific Features of Microglia from Adult Mice. Cell Rep [Internet]. 2018 [cited 2024 Jun 5];23:3501\u201311. https:\/\/pubmed.ncbi.nlm.nih.gov\/29924994\/","DOI":"10.1016\/j.celrep.2018.05.048"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-024-01186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-024-01186-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-024-01186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T13:04:22Z","timestamp":1733403862000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-024-01186-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1186"],"URL":"https:\/\/doi.org\/10.1186\/s13550-024-01186-3","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the principles of the Declaration of Helsinki. All subjects were adults (>\u200918 years old), and provided written informed consent. The study was approved by the Ethics Committee of the Hospital District of Southwest Finland.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"123"}}